During the past decade, CRS Clinical Research Services Mannheim GmbH conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 8 clinical trials were completed, i.e. on average, 15.7% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 8 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CRS Clinical Research Services Mannheim GmbH" #1 sponsor was "Boehringer Ingelheim" with 27 trials, followed by "Bayer" with 9 trials sponsored, "Actelion" with 3 trials sponsored, "BioNTech SE" with 3 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CRS Clinical Research Services Mannheim GmbH" #1 collaborator was "CRS Clinical Research Services" with 1 trials as a collaborator, "Innovative Medicines Initiative" with 1 trials as a collaborator, "Key2Compliance" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "CRS Clinical Research Services Mannheim GmbH" are "Healthy" (29 trials), "Healthy Subjects" (4 trials), "COVID-19" (3 trials), "Asthma" (2 trials) and "Endometriosis" (2 trials). Many other conditions were trialed in "CRS Clinical Research Services Mannheim GmbH" in a lesser frequency.

Most popular intervention types in "CRS Clinical Research Services Mannheim GmbH" are "Drug" (47 trials), "Biological" (6 trials), "Other" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Midazolam" (5 trials), "BI 1358894" (3 trials), "BI 425809" (3 trials) and "BNT162b2" (3 trials). Other intervention names were less common.

The vast majority of trials in "CRS Clinical Research Services Mannheim GmbH" are 27 trials for "Male" genders, 24 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "CRS Clinical Research Services Mannheim GmbH". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in CRS Clinical Research Services Mannheim GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CRS Clinical Research Services Mannheim GmbH, 49 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".